Literature DB >> 20041306

Predictors of response to cardiac resynchronization therapy: the holy grail of electrophysiology.

Haisam Ismail, Amgad N Makaryus.   

Abstract

Mesh:

Year:  2009        PMID: 20041306     DOI: 10.1007/s10554-009-9556-9

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


× No keyword cloud information.
  16 in total

1.  Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study.

Authors:  S Cazeau; P Bordachar; G Jauvert; A Lazarus; C Alonso; M C Vandrell; J Mugica; P Ritter
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

2.  Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation.

Authors:  Jeroen J Bax; Thomas H Marwick; Sander G Molhoek; Gabe B Bleeker; Lieselot van Erven; Eric Boersma; Paul Steendijk; Ernst E van der Wall; Martin J Schalij
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

3.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

4.  Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; Jeffrey Wing-Hong Fung; Qing Zhang; Chi-Kin Chan; Yat-Sun Chan; Hong Lin; Leo C C Kum; Shun-Ling Kong; Yan Zhang; John E Sanderson
Journal:  Circulation       Date:  2004-06-14       Impact factor: 29.690

5.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

6.  Usefulness of the peak velocity difference by tissue Doppler imaging technique as an effective predictor of response to cardiac resynchronization therapy.

Authors:  Dean Notabartolo; John D Merlino; Andrew L Smith; David B DeLurgio; Fernando V Vera; Kirk A Easley; Randolph P Martin; Angel R León
Journal:  Am J Cardiol       Date:  2004-09-15       Impact factor: 2.778

Review 7.  Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators.

Authors:  L A Saxon; J P Boehmer; J Hummel; S Kacet; T De Marco; G Naccarelli; E Daoud
Journal:  Am J Cardiol       Date:  1999-03-11       Impact factor: 2.778

8.  Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.

Authors:  Jeroen J Bax; Gabe B Bleeker; Thomas H Marwick; Sander G Molhoek; Eric Boersma; Paul Steendijk; Ernst E van der Wall; Martin J Schalij
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

9.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

10.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

View more
  1 in total

1.  Implementation of Contraction to Electrophysiological Ventricular Myocyte Models, and Their Quantitative Characterization via Post-Extrasystolic Potentiation.

Authors:  Yanyan Claire Ji; Richard A Gray; Flavio H Fenton
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.